Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants

Sanat Kumar Barua; Jagadish Chandra Das; Mohammad Maruf-UL-Quader; Zabeen Chowdhury; Salina Haque; Muhammad Jabed Bin Amin Chowdhury; Aparup Kanti Das; Dhiman Chowdhury

doi:doi:10.11648/j.ajp.20230904.13

Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants

Sanat Kumar Barua, Jagadish Chandra Das, Mohammad Maruf-UL-Quader, Zabeen Chowdhury, Salina Haque, Muhammad Jabed Bin Amin Chowdhury, Aparup Kanti Das, Dhiman Chowdhury

Published in American Journal of Pediatrics (Volume 9, Issue 4)

Received: 11 September 2023 Accepted: 28 September 2023 Published: 14 October 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Human milk oligosaccharides (HMOs) constitute a significant and intriguing component of human milk, ranking as the third most abundant solid constituent following lactose and lipids. Meanwhile, gut microbiota encompasses an array of microorganisms, spanning bacteria, archaea, fungi, and viruses, residing within the digestive tract. The intricate interplay among human milk oligosaccharides (HMOs), gut microbiota, and the immune system holds substantial implications for the initial developmental stages of newborns. This comprehensive review aimed to delve into the multifaceted role of HMOs in molding gut microbiota and their profound contribution to the maturation of the immune system in neonates. By conducting a meticulous systematic review of pertinent literature, this study explored the intricate interrelationships among HMOs, gut microbiota, and the immune system in newborn infants. The review analyzed a substantial corpus of recently published original research articles and comprehensive review papers. Google Scholar, PubMed, and SCOPUS served as robust and dependable sources for data acquisition. Besides these, some other reliable sources were also used. Through this article, readers will acquire a lucid comprehension of HMOs' pivotal role in shaping gut microbiota dynamics and fostering immune system maturation in neonates. The insights garnered from these interactions hold the promise of steering interventions geared toward optimizing neonatal health outcomes. Nonetheless, further research is imperative to unveil specific underlying mechanisms and potential therapeutic avenues.

Published in	American Journal of Pediatrics (Volume 9, Issue 4)
DOI	10.11648/j.ajp.20230904.13
Page(s)	204-209
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Human Milk, Oligosaccharides, HMOs, Neonatal Immunity, Gut Microbiota, Digestive Tract

References

[1]	Gura T. Nature's first functional food. Science (2014) 345: 747-9. doi: 10.1126/science.345.6198.747.
[2]	Bode L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology (2012) 22: 1147-62. doi: 10.1093/glycol/cws074.
[3]	Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH, et al. A strategy for annotating the human milk glycome. J Agric Food Chem. (2006) 54: 7471-80. doi: 10.1021/jf0615810.
[4]	Rudloff S, Pohlentz G, Borsch C, Lentze MJ, Kunz C. Urinary excretion of in vivo 13C-labelled milk oligosaccharides in breastfed infants. Br J Nutr. (2012) 107: 957-63. doi: 10.1017/S0007114511004016.
[5]	Davis EC, Wang M, Donovan SM. The role of early life nutrition in the establishment of gastrointestinal microbial composition and function. Gut Microbes (2017) 8: 143-71. doi: 10.1080/19490976.2016.1278104.
[6]	Newburg DS, Ko JS, Leone S, Nanthakumar NN. Human milk oligosaccharides and synthetic galactosyloligosaccharides contain 3′-, 4-, and 6′-galactosyl lactose and attenuate inflammation in human T84, NCM-460, and H4 cells and intestinal tissue ex vivo. J Nutr. (2016) 146: 358–67. doi: 10.3945/jn.115.220749.
[7]	Laucirica DR, Triantis V, Schoemaker R, Estes MK, Ramani S. Milk oligosaccharides inhibit human rotavirus infectivity in MA104 cells. J Nutr. (2017) 147: 1709-14. doi: 10.3945/jn.116.246090.
[8]	Lin AE, Autran CA, Espanola SD, Bode L, Nizet V. Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. J Infect Dis. (2014) 209: 389-98. doi: 10.1093/infdis/jit464.
[9]	Seppo AE, Autran CA, Bode L, Järvinen KM. Human milk oligosaccharides and development of cow's milk allergy in infants. J Allergy Clin Immunol. (2017) 139: 708-11. doi: 10.1016/j.jaci.2016.08.031.
[10]	Oliveros E, Ramirez M, Vazquez E, Barranco A, Gruart A, Delgado-Garcia JM, et al. Oral Supplementation of 2′-fucosyllactose during lactation improves memory and learning in rats. J Nutr Biochem. (2016) 31: 20-7. doi: 10.1016/j.jnutbio.2015.12.014.
[11]	Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr. (2000) 71: 1589-96. doi: 10.1093/ajcn/71.6.1589.
[12]	Gnoth MJ, Rudloff S, Kunz C, Kinne RK. Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high-performance liquid chromatography-mass spectrometry technique. J Biol Chem. (2001) 276: 34363-70. doi: 10.1074/jbc.M104805200.
[13]	Dotz V, Rudloff S, Meyer C, Lochnit G, Kunz C. Metabolic fate of neutral human milk oligosaccharides in exclusively breast-fed infants. Mol Nutr Food Res. (2015) 59: 355-64. doi: 10.1002/mnfr.201400160.
[14]	Albrecht S, Schols HA., Van Den Heuvel EGHM, Voragen AGJ, Gruppen H. Occurrence of oligosaccharides in feces of breast-fed babies in their first six months of life and the corresponding breast milk. Carbohydr Res. (2011) 346: 2540-50. doi: 10.1016/j.carres.2011.08.009.
[15]	Alexanderson K, Norlund A. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 2. Methods used for the systematic literature search and for the review of relevance, quality, and evidence of studies. Scand J Public Health Suppl. 2004; 63: 31-5. doi: 10.1080/14034950410021826. PMID: 15513651.
[16]	Coppa GV, Gabrielli O, Pierani P, Catassi C, Carlucci A, Giorgi PL. 1993. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics 91: 637-41.
[17]	Wu S, Tao N, German JB, Grimm R, Lebrilla CB. 2010. Development of an annotated library of neutral human milk oligosaccharides. J. Proteome Res. 9: 4138-51.
[18]	Wu SA, Grimm R, German JB, Lebrilla CB. 2011. Annotation and structural analysis of sialylated human milk oligosaccharides. J. Proteome Res. 10: 856-68.
[19]	Smilowitz JT, O’Sullivan A, Barile D, German JB, Lo¨ nnerdal B, Slupsky CM. 2013. The human milk metabolome reveals diverse oligosaccharide proﬁles. J. Nutr. 143: 1709-18.
[20]	Smilowitz, Jennifer T., et al. "Breast milk oligosaccharides: structure-function relationships in the neonate." Annual review of nutrition 34 (2014): 143-169.
[21]	Fong B, Ma K, McJarrow P. 2011. Quantiﬁcation of bovine milk oligosaccharides using liquid chromatography-selected reaction monitoring-mass spectrometry. J. Agric. Food Chem. 59: 9788-95.
[22]	Tao N, Wu S, Kim J, An HJ, Hinde K, et al. 2011. Evolutionary glycomics: characterization of milk oligosaccharides in primates. J. Proteome Res. 10: 1548–57.
[23]	Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, et al. 2011. Preterm milk oligosaccharides during the ﬁrst month of lactation. Pediatrics 128: e1520-31.
[24]	Kunz C, Rudloff S, Baier W, Klein N, Strobel S. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 20: 699-722.
[25]	Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, et al. 2012. Comprehensive proﬁles of human milk oligosaccharides yield highly sensitive and speciﬁc markers for determining secretor status in lactating mothers. J. Proteome Res. 11: 6124-33.
[26]	Zhang, Shunhao, et al. "Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota." Microbial cell factories 20.1 (2021): 1-16.
[27]	Jost T, Lacroix C, Braegger C, Chassard C. Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health. Nutr Rev. 2015; 73 (7): 426–37. https://doi.org/10.1093/nutrit/ nuu016.
[28]	Hao H, Zhu L, Faden HS. The milk-based diet of infancy and the gut microbiome. Gastroenterol Rep. 2019; 7 (4): 246-9. https://doi.org/10. 1093/gastro/goz031.
[29]	James K, O’Connell Motherway M, Penno C, O’Brien RL, van Sinderen D. Bifidobacterium breve UCC2003 employs multiple transcriptional regulators to control the metabolism of particular human milk oligosaccharides. Appl Environ Microbiol. 2018. https://doi.org/10.1128/AEM.02774-17.
[30]	Bottacini F, Ventura M, van Sinderen D, O’Connell Motherway M. Diversity, ecology and intestinal function of bifidobacteria. Microb Cell Fact. 2014; 13 (Suppl 1): S4. https://doi.org/10.1186/1475-2859-13-S1-S4.
[31]	Gotoh A, Katoh T, Sakanaka M, Ling Y, Yamada C, Asakuma S, Urashima T, Tomabechi Y, Katayama-Ikegami A, Kurihara S, Yamamoto K, Harata G, He F, Hirose J, Kitaoka M, Okuda S, Katayama T. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Sci Rep. 2018; 8 (1): 13958. https://doi.org/10.1038/s41598-018-32080-3.
[32]	Garrido D, Ruiz-Moyano S, Kirmiz N, Davis JC, Totten SM, Lemay DG, Ugalde JA, German JB, Lebrilla CB, Mills DA. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596. Sci Rep. 2016; 6: 35045. https://doi. org/10.1038/srep35045.
[33]	Ploger S, Stumpff F, Penner GB, Schulzke JD, Gabel G, Martens H, Shen Z, Gunzel D, Aschenbach JR. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci. 2012; 1258: 52-9. https://doi.org/10.1111/j.1749-6632.2012.06553.x.
[34]	Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, Flint HJ, Louis P. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014; 8 (6): 1323-35. https://doi.org/10.1038/ismej.2014.14.
[35]	Schwab C, Ruscheweyh HJ, Bunesova V, Pham VT, Beerenwinkel N, Lacroix C. Trophic interactions of infant bifidobacteria and Eubacterium hallii during L-fucose and fucosyllactose degradation. Front Microbiol. 2017; 8: 95. https://doi.org/10.3389/fmicb.2017.00095.
[36]	Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev. 2005; 85 (4): 1159-204. https://doi. org/10.1152/physrev.00003.2005.
[37]	Foata F, Sprenger N, Rochat F, Damak S. Activation of the G-protein coupled receptor GPR35 by human milk oligosaccharides through different pathways. Sci Rep. 2020; 10 (1): 16117. https://doi.org/10.1038/ s41598-020-73008-0.
[38]	He Y, Liu S, Kling DE, Leone S, Lawlor NT, Huang Y, Feinberg SB, Hill DR, Newburg DS. The human milk oligosaccharide 2’-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation. Gut. 2016; 65 (1): 33-46. https://doi.org/ 10.1136/gutjnl-2014-307544.
[39]	Dogaru CM, Nyffenegger D, Pescatore AM, Spycher BD, Kuehni CE. Breastfeeding and childhood asthma: systematic review and meta-analysis. Am J Epidemiol. 2014; 179 (10): 1153–67. https://doi.org/10. 1093/aje/kwu072.
[40]	Donovan SM. Summary on clinical aspects of human milk on infant health outcomes. Nestle Nutr Inst Workshop Ser. 2019; 90: 175–8. https:// doi.org/10.1159/000490485.
[41]	Horta BL, Loret C, de Mola CG, Victora. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015; 104 (467): 30-7. https://doi.org/10.1111/apa.13133.
[42]	Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS. 2000; 108 (1): 1-28. https://doi.org/10.1034/j.1600-0463.2000.d01-1.x.
[43]	Huang P, Morrow AL, Jiang X. The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition. Glycoconj J. 2009; 26 (8): 1085–96. https://doi.org/10.1007/s10719-009-9229-x.
[44]	Shirley DT, Farr L, Watanabe K, Moonah S. A review of the global burden, new diagnostics, and current therapeutics for Amebiasis. Open Forum Infect Dis. 2018; 5 (7): ofy161. https://doi.org/10.1093/ofid/ofy161.
[45]	Greenberg RG, Benjamin DK Jr. Neonatal candidiasis: diagnosis, prevention, and treatment. J Infect. 2014; 69 (Suppl 1): S19-22. https://doi.org/ 10.1016/j.jinf.2014.07.012.

Cite This Article

Plain Text BibTeX RIS

APA Style

Sanat Kumar Barua, Jagadish Chandra Das, Mohammad Maruf-UL-Quader, Zabeen Chowdhury, Salina Haque, et al. (2023). Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants. American Journal of Pediatrics, 9(4), 204-209. https://doi.org/10.11648/j.ajp.20230904.13

Copy | Download

ACS Style

Sanat Kumar Barua; Jagadish Chandra Das; Mohammad Maruf-UL-Quader; Zabeen Chowdhury; Salina Haque, et al. Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants. Am. J. Pediatr. 2023, 9(4), 204-209. doi: 10.11648/j.ajp.20230904.13

Copy | Download

AMA Style

Sanat Kumar Barua, Jagadish Chandra Das, Mohammad Maruf-UL-Quader, Zabeen Chowdhury, Salina Haque, et al. Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants. Am J Pediatr. 2023;9(4):204-209. doi: 10.11648/j.ajp.20230904.13

Copy | Download

@article{10.11648/j.ajp.20230904.13,
  author = {Sanat Kumar Barua and Jagadish Chandra Das and Mohammad Maruf-UL-Quader and Zabeen Chowdhury and Salina Haque and Muhammad Jabed Bin Amin Chowdhury and Aparup Kanti Das and Dhiman Chowdhury},
  title = {Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants},
  journal = {American Journal of Pediatrics},
  volume = {9},
  number = {4},
  pages = {204-209},
  doi = {10.11648/j.ajp.20230904.13},
  url = {https://doi.org/10.11648/j.ajp.20230904.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20230904.13},
  abstract = {Human milk oligosaccharides (HMOs) constitute a significant and intriguing component of human milk, ranking as the third most abundant solid constituent following lactose and lipids. Meanwhile, gut microbiota encompasses an array of microorganisms, spanning bacteria, archaea, fungi, and viruses, residing within the digestive tract. The intricate interplay among human milk oligosaccharides (HMOs), gut microbiota, and the immune system holds substantial implications for the initial developmental stages of newborns. This comprehensive review aimed to delve into the multifaceted role of HMOs in molding gut microbiota and their profound contribution to the maturation of the immune system in neonates. By conducting a meticulous systematic review of pertinent literature, this study explored the intricate interrelationships among HMOs, gut microbiota, and the immune system in newborn infants. The review analyzed a substantial corpus of recently published original research articles and comprehensive review papers. Google Scholar, PubMed, and SCOPUS served as robust and dependable sources for data acquisition. Besides these, some other reliable sources were also used. Through this article, readers will acquire a lucid comprehension of HMOs' pivotal role in shaping gut microbiota dynamics and fostering immune system maturation in neonates. The insights garnered from these interactions hold the promise of steering interventions geared toward optimizing neonatal health outcomes. Nonetheless, further research is imperative to unveil specific underlying mechanisms and potential therapeutic avenues.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants
AU  - Sanat Kumar Barua
AU  - Jagadish Chandra Das
AU  - Mohammad Maruf-UL-Quader
AU  - Zabeen Chowdhury
AU  - Salina Haque
AU  - Muhammad Jabed Bin Amin Chowdhury
AU  - Aparup Kanti Das
AU  - Dhiman Chowdhury
Y1  - 2023/10/14
PY  - 2023
N1  - https://doi.org/10.11648/j.ajp.20230904.13
DO  - 10.11648/j.ajp.20230904.13
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 204
EP  - 209
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20230904.13
AB  - Human milk oligosaccharides (HMOs) constitute a significant and intriguing component of human milk, ranking as the third most abundant solid constituent following lactose and lipids. Meanwhile, gut microbiota encompasses an array of microorganisms, spanning bacteria, archaea, fungi, and viruses, residing within the digestive tract. The intricate interplay among human milk oligosaccharides (HMOs), gut microbiota, and the immune system holds substantial implications for the initial developmental stages of newborns. This comprehensive review aimed to delve into the multifaceted role of HMOs in molding gut microbiota and their profound contribution to the maturation of the immune system in neonates. By conducting a meticulous systematic review of pertinent literature, this study explored the intricate interrelationships among HMOs, gut microbiota, and the immune system in newborn infants. The review analyzed a substantial corpus of recently published original research articles and comprehensive review papers. Google Scholar, PubMed, and SCOPUS served as robust and dependable sources for data acquisition. Besides these, some other reliable sources were also used. Through this article, readers will acquire a lucid comprehension of HMOs' pivotal role in shaping gut microbiota dynamics and fostering immune system maturation in neonates. The insights garnered from these interactions hold the promise of steering interventions geared toward optimizing neonatal health outcomes. Nonetheless, further research is imperative to unveil specific underlying mechanisms and potential therapeutic avenues.
VL  - 9
IS  - 4
ER  -

Copy | Download

Author Information

Sanat Kumar Barua

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Jagadish Chandra Das

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Mohammad Maruf-UL-Quader

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Zabeen Chowdhury

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Salina Haque

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Muhammad Jabed Bin Amin Chowdhury

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Aparup Kanti Das

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh
Dhiman Chowdhury

Department of Paediatrics, Chittagong Medical College, Chittagong, Bangladesh

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Sanat Kumar Barua, Jagadish Chandra Das, Mohammad Maruf-UL-Quader, Zabeen Chowdhury, Salina Haque, et al. (2023). Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants. American Journal of Pediatrics, 9(4), 204-209. https://doi.org/10.11648/j.ajp.20230904.13

Copy | Download

ACS Style

Sanat Kumar Barua; Jagadish Chandra Das; Mohammad Maruf-UL-Quader; Zabeen Chowdhury; Salina Haque, et al. Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants. Am. J. Pediatr. 2023, 9(4), 204-209. doi: 10.11648/j.ajp.20230904.13

Copy | Download

AMA Style

Sanat Kumar Barua, Jagadish Chandra Das, Mohammad Maruf-UL-Quader, Zabeen Chowdhury, Salina Haque, et al. Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants. Am J Pediatr. 2023;9(4):204-209. doi: 10.11648/j.ajp.20230904.13

Copy | Download

@article{10.11648/j.ajp.20230904.13,
  author = {Sanat Kumar Barua and Jagadish Chandra Das and Mohammad Maruf-UL-Quader and Zabeen Chowdhury and Salina Haque and Muhammad Jabed Bin Amin Chowdhury and Aparup Kanti Das and Dhiman Chowdhury},
  title = {Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants},
  journal = {American Journal of Pediatrics},
  volume = {9},
  number = {4},
  pages = {204-209},
  doi = {10.11648/j.ajp.20230904.13},
  url = {https://doi.org/10.11648/j.ajp.20230904.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20230904.13},
  abstract = {Human milk oligosaccharides (HMOs) constitute a significant and intriguing component of human milk, ranking as the third most abundant solid constituent following lactose and lipids. Meanwhile, gut microbiota encompasses an array of microorganisms, spanning bacteria, archaea, fungi, and viruses, residing within the digestive tract. The intricate interplay among human milk oligosaccharides (HMOs), gut microbiota, and the immune system holds substantial implications for the initial developmental stages of newborns. This comprehensive review aimed to delve into the multifaceted role of HMOs in molding gut microbiota and their profound contribution to the maturation of the immune system in neonates. By conducting a meticulous systematic review of pertinent literature, this study explored the intricate interrelationships among HMOs, gut microbiota, and the immune system in newborn infants. The review analyzed a substantial corpus of recently published original research articles and comprehensive review papers. Google Scholar, PubMed, and SCOPUS served as robust and dependable sources for data acquisition. Besides these, some other reliable sources were also used. Through this article, readers will acquire a lucid comprehension of HMOs' pivotal role in shaping gut microbiota dynamics and fostering immune system maturation in neonates. The insights garnered from these interactions hold the promise of steering interventions geared toward optimizing neonatal health outcomes. Nonetheless, further research is imperative to unveil specific underlying mechanisms and potential therapeutic avenues.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Human Milk Oligosaccharides and Development of Gut Microbiota with Immune System in Newborn Infants
AU  - Sanat Kumar Barua
AU  - Jagadish Chandra Das
AU  - Mohammad Maruf-UL-Quader
AU  - Zabeen Chowdhury
AU  - Salina Haque
AU  - Muhammad Jabed Bin Amin Chowdhury
AU  - Aparup Kanti Das
AU  - Dhiman Chowdhury
Y1  - 2023/10/14
PY  - 2023
N1  - https://doi.org/10.11648/j.ajp.20230904.13
DO  - 10.11648/j.ajp.20230904.13
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 204
EP  - 209
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20230904.13
AB  - Human milk oligosaccharides (HMOs) constitute a significant and intriguing component of human milk, ranking as the third most abundant solid constituent following lactose and lipids. Meanwhile, gut microbiota encompasses an array of microorganisms, spanning bacteria, archaea, fungi, and viruses, residing within the digestive tract. The intricate interplay among human milk oligosaccharides (HMOs), gut microbiota, and the immune system holds substantial implications for the initial developmental stages of newborns. This comprehensive review aimed to delve into the multifaceted role of HMOs in molding gut microbiota and their profound contribution to the maturation of the immune system in neonates. By conducting a meticulous systematic review of pertinent literature, this study explored the intricate interrelationships among HMOs, gut microbiota, and the immune system in newborn infants. The review analyzed a substantial corpus of recently published original research articles and comprehensive review papers. Google Scholar, PubMed, and SCOPUS served as robust and dependable sources for data acquisition. Besides these, some other reliable sources were also used. Through this article, readers will acquire a lucid comprehension of HMOs' pivotal role in shaping gut microbiota dynamics and fostering immune system maturation in neonates. The insights garnered from these interactions hold the promise of steering interventions geared toward optimizing neonatal health outcomes. Nonetheless, further research is imperative to unveil specific underlying mechanisms and potential therapeutic avenues.
VL  - 9
IS  - 4
ER  -

Copy | Download